A 48-year-old woman underwent a thyroidectomy with central neck dissection due to papillary thyroid carcinoma. On day 2 postoperatively, she developed irritability, dysphagia, difficulty breathing, and spasms in different muscle groups in her upper and lower extremities. The vital signs include blood pressure 102/65 mm Hg, heart rate 93/min, respiratory rate 17/min, and temperature 36.1℃ (97.0℉). Physical examination shows several petechiae on her forearms, muscle twitching in her upper and lower extremities, expiratory wheezes on lung auscultation, decreased S1 and S2 and the presence of an S3 on cardiac auscultation, and positive Trousseau and Chvostek signs. Laboratory studies show:
Ca2+ 4.4 mg/dL
Mg2+ 1.7 mEq/L
Na+ 140 mEq/L
K+ 4.3 mEq/L
Cl- 107 mEq/L
HCO3- 25 mEq/L
Administration of which of the following agents could prevent the patient’s condition?
Q632
A 25-year-old man presents to the emergency department after a motor vehicle accident. He was the unrestrained front seat driver in a head on collision. The patient is unresponsive and his medical history is unknown. His temperature is 99.5°F (37.5°C), blood pressure is 67/38 mmHg, pulse is 190/min, respirations are 33/min, and oxygen saturation is 98% on room air. The patient is started on IV fluids, blood products, and norepinephrine. A FAST exam is performed and a pelvic binder is placed. One hour later, his temperature is 98.3°F (36.8°C), blood pressure is 119/66 mmHg, pulse is 110/min, respirations are 15/min, and oxygen saturation is 97% on room air. The patient is currently responsive. Management of the patient's pelvic fracture is scheduled by the orthopedic service. While the patient is waiting in the emergency department he suddenly complains of feeling hot, aches, and a headache. The patient's temperature is currently 101°F (38.3°C). He has not been given any pain medications and his past medical history is still unknown. Which of the following is the most likely diagnosis?
Q633
A 16-year-old boy with history of seizure disorder is rushed to the Emergency Department with multiple generalized tonic-clonic seizures that have spanned more than 30 minutes in duration. He has not regained consciousness between these episodes. In addition to taking measures to ensure that he maintains adequate respiration, which of the following is appropriate for initial pharmacological therapy?
Q634
A 60-year-old male presents to the emergency room complaining of substernal chest pain. He reports a three-hour history of dull substernal chest pain that radiates into his left arm and jaw. He had a similar incident two months ago after walking one mile, but this pain is more severe. His past medical history is notable for hypertension and hyperlipidemia. An EKG demonstrates non-specific changes. Serum troponins are normal. In addition to aspirin, oxygen, and morphine, he is started on a medication that releases nitric oxide. Which of the following is a downstream effect of this molecule?
Q635
A 5-year-old boy undergoes MRI neuroimaging for the evaluation of worsening headaches and intermittent nausea upon awakening. He receives a bolus of intravenous thiopental for sedation during the procedure. Ten minutes after the MRI, the patient is awake and responsive. Which of the following pharmacological properties is most likely responsible for this patient's rapid recovery from this anesthetic agent?
Q636
A 70-year-old Caucasian male presents to the emergency room following a fall. The patient's past medical history is significant for myocardial infarction and atrial fibrillation. His home medications are unknown. The patient's head CT is shown in Image A. Laboratory results reveal an International Normalized Ratio (INR) of 6. Which of the following is the most appropriate pharmacologic therapy for this patient?
Q637
A 57-year-old man presents to the emergency department for evaluation of slurred speech and left arm and leg weakness over the last 3 hours. History reveals hypertension that is being treated with hydrochlorothiazide. Vital signs include: blood pressure of 110/70 mm Hg, heart rate 104/min, respiratory rate 18/min, and temperature 36.6°C (98.0°F). Physical examination reveals 2/5 strength in both left upper and lower extremities. After 2 hours, the patient’s symptoms suddenly disappear. An electrocardiogram (ECG) is obtained (see image). Which of the following medications could prevent ischemic attacks in this patient in the future?
Q638
A 66-year-old man is brought to the emergency department 1 hour after the abrupt onset of painless loss of vision in his left eye. Over the last several years, he has noticed increased blurring of vision; he says the blurring has made it difficult to read, but he can read better if he holds the book below or above eye level. He has smoked 1 pack of cigarettes daily for 40 years. Fundoscopic examination shows subretinal fluid and small hemorrhage with grayish-green discoloration in the macular area in the left eye, and multiple drusen in the right eye with retinal pigment epithelial changes. Which of the following is the most appropriate pharmacotherapy for this patient's eye condition?
Q639
A 35-year-old woman presents to the clinic with a 2-week history of headaches. She was in her usual state of health until 2 weeks ago, when she started having headaches. The headaches are throughout her whole head and rated as a 7/10. They are worse in the mornings and when she bends over. She has some mild nausea, but no vomiting. The headaches are not throbbing and are not associated with photophobia or phonophobia. On further questioning, she has noticed more hair than usual on her pillow in the morning and coming out in her hands when she washes her hair. The past medical history is unremarkable; she takes no prescription medications, but for the past year she has been taking an oral 'health supplement' recommended by her sister, which she orders over the internet. She cannot recall the supplement's name and does not know its contents. The physical exam is notable for some mild hepatomegaly but is otherwise unremarkable. This patient's presentation is most likely related to which of the following micronutrients?
Q640
A 22-year-old woman with type 1 diabetes mellitus and mild asthma comes to the physician for a follow-up examination. She has had several episodes of sweating, dizziness, and nausea in the past 2 months that occur during the day and always resolve after she drinks orange juice. She is compliant with her diet and insulin regimen. The physician recommends lowering her insulin dose in certain situations. This recommendation is most important in which of the following situations?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 631: A 48-year-old woman underwent a thyroidectomy with central neck dissection due to papillary thyroid carcinoma. On day 2 postoperatively, she developed irritability, dysphagia, difficulty breathing, and spasms in different muscle groups in her upper and lower extremities. The vital signs include blood pressure 102/65 mm Hg, heart rate 93/min, respiratory rate 17/min, and temperature 36.1℃ (97.0℉). Physical examination shows several petechiae on her forearms, muscle twitching in her upper and lower extremities, expiratory wheezes on lung auscultation, decreased S1 and S2 and the presence of an S3 on cardiac auscultation, and positive Trousseau and Chvostek signs. Laboratory studies show:
Ca2+ 4.4 mg/dL
Mg2+ 1.7 mEq/L
Na+ 140 mEq/L
K+ 4.3 mEq/L
Cl- 107 mEq/L
HCO3- 25 mEq/L
Administration of which of the following agents could prevent the patient’s condition?
A. Anticonvulsants prior to and for 1 week after the operation
B. Vitamin D and ionic calcium prior to and 2 weeks after the operation (Correct Answer)
C. Potassium supplementation prior to and 2 weeks after the operation
D. Calcium gluconate intraoperatively
E. Magnesium sulfate intraoperatively
Explanation: ***Vitamin D and ionic calcium prior to and 2 weeks after the operation***
- The patient's symptoms are consistent with **hypocalcemia** (low calcium), a common complication after thyroidectomy due to inadvertent parathyroid gland removal or damage. Prophylactic **calcium and vitamin D supplementation** can prevent severe postoperative hypocalcemia by helping maintain calcium homeostasis.
- The patient's calcium level of 4.4 mg/dL (normal range 8.5-10.2 mg/dL) confirms severe hypocalcemia. The presence of **Trousseau and Chvostek signs**, muscle spasms, and dysphagia are classic signs of hypocalcemic tetany.
*Anticonvulsants prior to and for 1 week after the operation*
- This patient's symptoms are not indicative of an underlying seizure disorder, but rather **neuromuscular excitability** due to hypocalcemia. Anticonvulsants would not address the root cause.
- While severe hypocalcemia can rarely lead to seizures, prophylactic anticonvulsant administration is not standard practice for preventing this specific post-thyroidectomy complication.
*Potassium supplementation prior to and 2 weeks after the operation*
- The patient's potassium level is 4.3 mEq/L, which is within the normal range (3.5-5.0 mEq/L). **Hyperkalemia or hypokalemia** is not the primary issue here.
- Potassium supplementation would not address the hypocalcemia causing her symptoms and could potentially lead to **hyperkalemia**, which has its own set of dangers.
*Calcium gluconate intraoperatively*
- **Intraoperative calcium gluconate** is typically used for acute, severe hypocalcemia or cardiac arrest, not as a prophylactic measure. Administering it intraoperatively would not prevent the delayed onset of hypocalcemia seen on day 2.
- The goal is to prevent hypocalcemia by supporting calcium levels proactively, rather than treating an acute drop during surgery, which is rare.
*Magnesium sulfate intraoperatively*
- The patient's magnesium level of 1.7 mEq/L is at the lower limit of normal (1.7-2.2 mEq/L). While **hypomagnesemia** can impair PTH secretion and cause refractory hypocalcemia, magnesium supplementation is not the primary prophylactic strategy for post-thyroidectomy hypocalcemia.
- Intraoperative magnesium sulfate would not address the fundamental issue of parathyroid gland injury or removal causing the hypocalcemia. Calcium and vitamin D remain the cornerstone of prevention.
Question 632: A 25-year-old man presents to the emergency department after a motor vehicle accident. He was the unrestrained front seat driver in a head on collision. The patient is unresponsive and his medical history is unknown. His temperature is 99.5°F (37.5°C), blood pressure is 67/38 mmHg, pulse is 190/min, respirations are 33/min, and oxygen saturation is 98% on room air. The patient is started on IV fluids, blood products, and norepinephrine. A FAST exam is performed and a pelvic binder is placed. One hour later, his temperature is 98.3°F (36.8°C), blood pressure is 119/66 mmHg, pulse is 110/min, respirations are 15/min, and oxygen saturation is 97% on room air. The patient is currently responsive. Management of the patient's pelvic fracture is scheduled by the orthopedic service. While the patient is waiting in the emergency department he suddenly complains of feeling hot, aches, and a headache. The patient's temperature is currently 101°F (38.3°C). He has not been given any pain medications and his past medical history is still unknown. Which of the following is the most likely diagnosis?
A. Acute hemolytic transfusion reaction
B. Febrile non-hemolytic transfusion reaction (Correct Answer)
C. Sympathetic response to pain
D. Minor blood group incompatibility
E. Leukoagglutination reaction
Explanation: ***Febrile non-hemolytic transfusion reaction***
- This reaction is characterized by a **fever** and other constitutional symptoms (chills, headache, malaise) developing **within 4 hours of transfusion**, without evidence of hemolysis. The patient's symptoms and temperature rise after blood product administration fit this description.
- It is typically caused by antibodies in the recipient's plasma reacting with **leukocyte antigens** present on donor white blood cells or by **cytokines** released from donor leukocytes during storage.
*Acute hemolytic transfusion reaction*
- This reaction typically presents with more severe symptoms such as **hypotension**, **hemoglobinuria**, flank pain, and diffuse bleeding, indicating widespread intravascular hemolysis due to **ABO incompatibility**.
- Although the patient received blood products, his symptoms (feeling hot, aches, headache, mild fever) are not indicative of the severe, life-threatening nature of an acute hemolytic reaction.
*Sympathetic response to pain*
- While pain can cause a sympathetic response (tachycardia, hypertension), it typically does **not cause a fever** as seen in this patient.
- The patient's initial presentation included signs of shock, and after resuscitation, his vital signs normalized before the new symptoms appeared, suggesting a new process rather than ongoing pain alone.
*Minor blood group incompatibility*
- Reactions to minor blood group incompatibilities are usually **milder and delayed** compared to ABO incompatibilities.
- They often involve **extravascular hemolysis**, which might not present with the acute febrile reaction seen here, and are less common a cause of immediate febrile reactions.
*Leukoagglutination reaction*
- This is an older term for what is now often considered a type of **febrile non-hemolytic transfusion reaction (FNHTR)** caused by recipient antibodies to donor leukocyte antigens leading to leukocyte clumping.
- While related to FNHTR, the term "febrile non-hemolytic transfusion reaction" is the more encompassing and appropriate diagnosis given the typical symptom complex of fever, chills, and headache.
Question 633: A 16-year-old boy with history of seizure disorder is rushed to the Emergency Department with multiple generalized tonic-clonic seizures that have spanned more than 30 minutes in duration. He has not regained consciousness between these episodes. In addition to taking measures to ensure that he maintains adequate respiration, which of the following is appropriate for initial pharmacological therapy?
A. Carbamazepine
B. Gabapentin
C. Lorazepam (Correct Answer)
D. Valproic acid
E. Phenytoin
Explanation: ***Lorazepam***
- This patient is experiencing **status epilepticus**, defined by continuous seizures lasting over 5 minutes or recurrent seizures without regaining consciousness. **Intravenous benzodiazepines**, like lorazepam, are the first-line treatment due to their rapid onset of action on GABA receptors.
- **Lorazepam** is preferred over other benzodiazepines in this setting due to its relatively **longer duration of action** and availability as an intravenous formulation, effectively terminating the acute seizure.
*Carbamazepine*
- **Carbamazepine** is an oral **anti-epileptic drug** used for long-term control of focal seizures, but it is not suitable for acute management of status epilepticus due to its **slow onset of action** and lack of intravenous formulation for rapid effect.
- It works by blocking **voltage-gated sodium channels**, which is not the primary mechanism for immediate seizure termination in an emergency.
*Gabapentin*
- **Gabapentin** is an anti-epileptic medication primarily used for focal seizures and neuropathic pain, and is **not effective** in treating acute generalized tonic-clonic seizures or status epilepticus.
- Its mechanism of action involves modulation of **calcium channels** and GABA, but it has a **slow onset** and limited efficacy in acute seizure termination.
*Valproic acid*
- **Valproic acid** can be used in the long-term management of various seizure types, including generalized tonic-clonic seizures, and has an intravenous formulation, but it is **not the first-line choice for immediate termination** of status epilepticus.
- Benzodiazepines are typically administered first, and if they fail, valproic acid can be considered as a **second-line agent** along with other antiepileptics.
*Phenytoin*
- **Phenytoin** is a classic anti-epileptic drug that can be used intravenously as a **second-line agent** for status epilepticus if benzodiazepines are unsuccessful.
- It has a slower onset of action compared to benzodiazepines and carries risks such as **cardiac arrhythmias** and **hypotension** with rapid infusion, making it less ideal for initial therapy.
Question 634: A 60-year-old male presents to the emergency room complaining of substernal chest pain. He reports a three-hour history of dull substernal chest pain that radiates into his left arm and jaw. He had a similar incident two months ago after walking one mile, but this pain is more severe. His past medical history is notable for hypertension and hyperlipidemia. An EKG demonstrates non-specific changes. Serum troponins are normal. In addition to aspirin, oxygen, and morphine, he is started on a medication that releases nitric oxide. Which of the following is a downstream effect of this molecule?
A. Guanylyl cyclase activation (Correct Answer)
B. cAMP production
C. L-type calcium channel inhibition
D. ß1-adrenergic antagonism
E. Prostaglandin synthesis inhibition
Explanation: ***Guanylyl cyclase activation***
- The medication releasing **nitric oxide (NO)** is **nitroglycerin**, an organic nitrate that undergoes bioconversion to release NO.
- **Nitric oxide** activates **soluble guanylyl cyclase** in vascular smooth muscle, leading to increased production of **cGMP (cyclic guanosine monophosphate)**.
- Increased cGMP causes **vascular smooth muscle relaxation**, resulting in **venodilation** (reducing preload) and **coronary vasodilation** (improving myocardial oxygen supply).
*cAMP production*
- **cAMP production** is mediated by **adenylyl cyclase**, typically activated by **beta-adrenergic receptors** or other G-protein coupled receptors.
- This is not the primary mechanism of nitric oxide signaling, which works through the cGMP pathway.
*L-type calcium channel inhibition*
- **L-type calcium channel inhibition** is the mechanism of action for **calcium channel blockers** (e.g., amlodipine, diltiazem, verapamil).
- These drugs directly block calcium channels, reducing cardiac contractility and vascular tone through a mechanism distinct from nitric oxide signaling.
*ß1-adrenergic antagonism*
- **ß1-adrenergic antagonism** is the primary mechanism of **beta-blockers** (e.g., metoprolol, atenolol), which reduce heart rate and myocardial contractility.
- This is a distinct pharmacological action unrelated to nitric oxide's downstream effects.
*Prostaglandin synthesis inhibition*
- **Prostaglandin synthesis inhibition** is the mechanism of action for **NSAIDs** including **aspirin**, which irreversibly inhibits cyclooxygenase (COX) enzymes.
- While aspirin is given to this patient for antiplatelet effects, it is not related to the nitric oxide-releasing medication.
Question 635: A 5-year-old boy undergoes MRI neuroimaging for the evaluation of worsening headaches and intermittent nausea upon awakening. He receives a bolus of intravenous thiopental for sedation during the procedure. Ten minutes after the MRI, the patient is awake and responsive. Which of the following pharmacological properties is most likely responsible for this patient's rapid recovery from this anesthetic agent?
A. First-pass metabolism
B. Redistribution (Correct Answer)
C. Zero-order elimination
D. Ion trapping
E. Cytochrome P450 oxidation
Explanation: ***Redistribution***
- Thiopental is a highly **lipid-soluble** drug that rapidly crosses the **blood-brain barrier**, leading to quick onset of action.
- The drug then rapidly **redistributes** from the brain to other highly perfused tissues (e.g., muscle, fat) and then less perfused tissues, causing a rapid decrease in drug concentration at the site of action and thus termination of the anesthetic effect.
*First-pass metabolism*
- This refers to the **metabolism of a drug** before it reaches systemic circulation, typically after oral administration, and does not explain the termination of action for an intravenously administered drug like thiopental.
- While thiopental is ultimately metabolized by the liver, this process is slower than redistribution and does not account for the **rapid awakening**.
*Zero-order elimination*
- **Zero-order elimination** occurs when a constant amount of drug is eliminated per unit of time, regardless of the drug's concentration, often seen with drug saturation of elimination pathways.
- Thiopental elimination follows **first-order kinetics** at therapeutic doses, meaning a constant fraction of the drug is eliminated per unit time, and this describes slower, overall elimination, not rapid recovery.
*Ion trapping*
- **Ion trapping** occurs when a drug accumulates in a compartment due to differences in pH across a membrane and the drug's pKa, leading to ionization and reduced ability to diffuse back.
- This mechanism is important for drug excretion or distribution into specific compartments (e.g., accumulation of basic drugs in acidic urine) but does not explain the **rapid termination of CNS effects** via redistribution.
*Cytochrome P450 oxidation*
- **Cytochrome P450 (CYP450) oxidation** is a major pathway for drug metabolism in the liver, which is responsible for the eventual elimination of thiopental from the body.
- While important for overall drug clearance, the rate of CYP450 oxidation is too slow to account for the **rapid awakening** seen after a single bolus dose of thiopental; redistribution is the primary factor for rapid recovery.
Question 636: A 70-year-old Caucasian male presents to the emergency room following a fall. The patient's past medical history is significant for myocardial infarction and atrial fibrillation. His home medications are unknown. The patient's head CT is shown in Image A. Laboratory results reveal an International Normalized Ratio (INR) of 6. Which of the following is the most appropriate pharmacologic therapy for this patient?
A. Platelet transfusion
B. Fresh frozen plasma (Correct Answer)
C. Protamine
D. Cryoprecipitate
E. Vitamin K
Explanation: ***Fresh frozen plasma***
- The patient has **intracranial hemorrhage (ICH)** with an elevated **INR of 6**, indicating **life-threatening warfarin-induced coagulopathy** that requires **immediate reversal**.
- **Fresh frozen plasma (FFP)** contains all coagulation factors and provides **immediate, though temporary, correction** of the coagulation defect, making it appropriate for emergency management when **prothrombin complex concentrate (PCC)** is unavailable.
- In critical bleeding like ICH, **time is of the essence**. While Vitamin K should also be administered for sustained reversal, it takes **12-24 hours** to work and is inadequate alone for emergency situations.
- The standard approach for warfarin-associated ICH includes: **FFP or PCC (for immediate reversal) + Vitamin K (for sustained correction)**.
*Vitamin K*
- **Vitamin K** is essential for **sustained correction** of warfarin-induced coagulopathy by promoting hepatic synthesis of **Factors II, VII, IX, and X**.
- However, Vitamin K takes **12-24 hours** to take effect, making it **inadequate as monotherapy** for life-threatening bleeding like ICH.
- It should be administered **in addition to** immediate reversal agents (FFP or PCC), not as the sole therapy.
*Platelet transfusion*
- **Platelet transfusions** are indicated for patients with **thrombocytopenia** or **platelet dysfunction** causing bleeding.
- This patient's coagulopathy is related to **factor deficiency/inhibition** (elevated INR), not platelet count or function.
*Protamine*
- **Protamine** is used to reverse the effects of **unfractionated heparin** and can partially reverse **low molecular weight heparin (LMWH)**.
- This patient's elevated **INR of 6** strongly suggests **warfarin** use (common for atrial fibrillation), not heparin.
- Heparin affects **aPTT**, not INR.
*Cryoprecipitate*
- **Cryoprecipitate** is a rich source of **Factor VIII**, **von Willebrand factor**, **fibrinogen**, and **Factor XIII**.
- It is primarily used for **fibrinogen replacement** or in specific bleeding disorders like **hemophilia A** or **von Willebrand disease**, not for broad reversal of warfarin-induced coagulopathy.
Question 637: A 57-year-old man presents to the emergency department for evaluation of slurred speech and left arm and leg weakness over the last 3 hours. History reveals hypertension that is being treated with hydrochlorothiazide. Vital signs include: blood pressure of 110/70 mm Hg, heart rate 104/min, respiratory rate 18/min, and temperature 36.6°C (98.0°F). Physical examination reveals 2/5 strength in both left upper and lower extremities. After 2 hours, the patient’s symptoms suddenly disappear. An electrocardiogram (ECG) is obtained (see image). Which of the following medications could prevent ischemic attacks in this patient in the future?
A. Warfarin (Correct Answer)
B. Acetylsalicylic acid
C. Enoxaparin
D. Heparin
E. Clopidogrel
Explanation: ***Warfarin***
- The patient experienced a **transient ischemic attack (TIA)** due to the sudden onset of neurological symptoms that resolved completely. The ECG shows **atrial fibrillation (AFib)**, characterized by an irregularly irregular rhythm and absence of P waves, which is a significant risk factor for cardioembolic stroke.
- **Oral anticoagulation** is essential for preventing ischemic stroke in patients with AFib. While **direct oral anticoagulants (DOACs)** such as apixaban, rivaroxaban, or dabigatran are now preferred as first-line therapy per current guidelines, **warfarin** remains an effective alternative and is the only oral anticoagulant option listed here.
- Warfarin prevents the formation of blood clots in the heart chambers by inhibiting vitamin K-dependent clotting factors, thereby reducing the risk of cardioembolic stroke.
*Acetylsalicylic acid*
- **Aspirin (acetylsalicylic acid)** is an antiplatelet agent used for primary and secondary prevention of ischemic stroke, particularly in patients with non-cardioembolic causes.
- While aspirin can be used in some cases, its efficacy in preventing stroke in patients with AFib is **significantly lower than that of oral anticoagulants** like warfarin or DOACs (reduces stroke risk by ~20% vs ~60-70% with anticoagulation).
*Enoxaparin*
- **Enoxaparin** is a low molecular weight heparin, an anticoagulant typically used for the **acute treatment** of deep vein thrombosis (DVT) and pulmonary embolism (PE), and sometimes as a bridge to warfarin therapy.
- It is not routinely used for **long-term prevention** of ischemic stroke in patients with AFib due to its parenteral (subcutaneous) administration and the need for daily injections.
*Heparin*
- **Heparin** (unfractionated) is an anticoagulant used for acute management of thrombotic events but requires continuous intravenous infusion and close monitoring of aPTT.
- Similar to enoxaparin, it is not practical or recommended for **long-term outpatient prophylaxis** against stroke in AFib.
*Clopidogrel*
- **Clopidogrel** is an antiplatelet agent that inhibits platelet aggregation via P2Y12 receptor blockade and is used in patients with atherosclerotic disease or as an alternative to aspirin in certain circumstances.
- It works by a different mechanism than anticoagulants and is generally **less effective than warfarin or DOACs** for preventing cardioembolic stroke from AFib (similar efficacy to aspirin alone).
Question 638: A 66-year-old man is brought to the emergency department 1 hour after the abrupt onset of painless loss of vision in his left eye. Over the last several years, he has noticed increased blurring of vision; he says the blurring has made it difficult to read, but he can read better if he holds the book below or above eye level. He has smoked 1 pack of cigarettes daily for 40 years. Fundoscopic examination shows subretinal fluid and small hemorrhage with grayish-green discoloration in the macular area in the left eye, and multiple drusen in the right eye with retinal pigment epithelial changes. Which of the following is the most appropriate pharmacotherapy for this patient's eye condition?
A. Ustekinumab
B. Etanercept
C. Cetuximab
D. Ruxolitinib
E. Ranibizumab (Correct Answer)
Explanation: ***Ranibizumab***
- The patient's presentation with **abrupt, painless vision loss**, **subretinal fluid**, hemorrhage, and grayish-green discoloration in the macula of the left eye, along with drusen and retinal pigment epithelial changes in the right, is highly suggestive of **wet age-related macular degeneration (AMD)**.
- **Ranibizumab** is an anti-VEGF (vascular endothelial growth factor) agent that inhibits neovascularization and leakage, making it the **approved first-line treatment for wet AMD**.
*Ustekinumab*
- This is a monoclonal antibody targeting **IL-12 and IL-23**, primarily used in the treatment of **psoriasis** and **psoriatic arthritis**, not wet AMD.
- It has no role in inhibiting VEGF pathways or treating retinal neovascularization.
*Etanercept*
- Etanercept is a **TNF-alpha inhibitor** used in conditions like **rheumatoid arthritis**, **psoriasis**, and **ankylosing spondylitis**.
- It does not target pathways involved in the pathogenesis of wet AMD.
*Cetuximab*
- Cetuximab is an **epidermal growth factor receptor (EGFR) inhibitor** used in the treatment of certain **cancers**, such as colorectal and head and neck cancers.
- It is not indicated for ophthalmological conditions like wet AMD.
*Ruxolitinib*
- Ruxolitinib is a **JAK (Janus kinase) inhibitor** primarily used for **myelofibrosis** and **polycythemia vera**.
- Its mechanism of action is unrelated to the treatment of neovascular AMD.
Question 639: A 35-year-old woman presents to the clinic with a 2-week history of headaches. She was in her usual state of health until 2 weeks ago, when she started having headaches. The headaches are throughout her whole head and rated as a 7/10. They are worse in the mornings and when she bends over. She has some mild nausea, but no vomiting. The headaches are not throbbing and are not associated with photophobia or phonophobia. On further questioning, she has noticed more hair than usual on her pillow in the morning and coming out in her hands when she washes her hair. The past medical history is unremarkable; she takes no prescription medications, but for the past year she has been taking an oral 'health supplement' recommended by her sister, which she orders over the internet. She cannot recall the supplement's name and does not know its contents. The physical exam is notable for some mild hepatomegaly but is otherwise unremarkable. This patient's presentation is most likely related to which of the following micronutrients?
A. Vitamin D
B. Vitamin B12
C. Vitamin C
D. Vitamin K
E. Vitamin A (Correct Answer)
Explanation: ***Vitamin A***
- The patient's symptoms, including **headaches worse in the mornings and with bending over**, **mild nausea**, and **diffuse hair loss**, along with **hepatomegaly**, are classic signs of **chronic vitamin A toxicity** (**hypervitaminosis A**).
- The likely source is a high-dose oral "health supplement" of unknown content, as vitamin A is a fat-soluble vitamin stored in the liver, leading to toxicity with excessive intake.
*Vitamin D*
- **Vitamin D toxicity** (hypervitaminosis D) typically presents with **hypercalcemia**, leading to symptoms like polyuria, polydipsia, renal stones, and muscle weakness, which are not described here.
- While headaches can occur, **hair loss** and **hepatomegaly** are not characteristic features of vitamin D toxicity.
*Vitamin B12*
- **Vitamin B12 toxicity** is extremely rare, as it is a water-soluble vitamin and excess is readily excreted.
- There are no well-established adverse effects or toxicity syndromes associated with high doses of vitamin B12 that would explain these symptoms.
*Vitamin C*
- **Vitamin C** is a water-soluble vitamin, and acute toxicity is uncommon because excess is excreted in urine.
- High doses can lead to **gastrointestinal upset** (diarrhea, nausea, abdominal cramps) and, rarely, kidney stones, but not the constellation of headache, hair loss, and hepatomegaly seen in this patient.
*Vitamin K*
- **Vitamin K toxicity** is generally rare and primarily associated with synthetic forms (menadione).
- In infants, high doses can cause **hemolytic anemia** and **jaundice**, but these symptoms are not typical for adults, nor do they explain the described presentation of headache, hair loss, and hepatomegaly.
Question 640: A 22-year-old woman with type 1 diabetes mellitus and mild asthma comes to the physician for a follow-up examination. She has had several episodes of sweating, dizziness, and nausea in the past 2 months that occur during the day and always resolve after she drinks orange juice. She is compliant with her diet and insulin regimen. The physician recommends lowering her insulin dose in certain situations. This recommendation is most important in which of the following situations?
A. After a stressful exam
B. During a viral infection
C. Before exercise (Correct Answer)
D. After large meals
E. During pregnancy
Explanation: ***Before exercise***
- Exercise increases **glucose utilization** by muscles, which can lead to **hypoglycemia** in individuals taking insulin if the dose isn't adjusted.
- The patient's symptoms (sweating, dizziness, nausea) are classic for **hypoglycemia**, which resolves with sugar intake (orange juice).
*After a stressful exam*
- **Stress** typically elevates **counter-regulatory hormones** (e.g., cortisol, epinephrine), which can increase blood glucose levels rather than cause hypoglycemia.
- An insulin dose reduction is usually not necessary and could lead to **hyperglycemia** in this situation.
*During a viral infection*
- Infections, even viral ones, often trigger the release of **stress hormones**, increasing glucose production and leading to **hyperglycemia** and increased insulin requirements.
- Insulin doses usually need to be *increased*, not decreased, during illness to manage elevated blood sugar.
*After large meals*
- Large meals, especially those rich in carbohydrates, would necessitate an **increased or consistent insulin dose** to cover the glucose intake and prevent **postprandial hyperglycemia**.
- Reducing insulin after a large meal would likely lead to uncontrolled high blood sugar rather than prevent hypoglycemia.
*During pregnancy*
- While insulin requirements can fluctuate throughout pregnancy, they generally **increase** in the second and third trimesters due to increased **insulin resistance**.
- Reducing insulin during pregnancy without careful monitoring could lead to uncontrolled **hyperglycemia**, posing risks to both mother and fetus.